Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment
Objective: To compare the long-term effects of carbamazepine (CBZ), valproic acid (VPA),
and lamotrigine (LTG) as monotherapy on the markers of vascular risk. Methods: The …
and lamotrigine (LTG) as monotherapy on the markers of vascular risk. Methods: The …
[PDF][PDF] Atherosclerotic risk among epileptic patients taking carbamazepine, phenytoin treatment: brief review
SS Khot, MH Shaikh, L Gupta - International Journal of Pharmaceutical …, 2013 - Citeseer
Epilepsy is a common chronic neurological disorder that requires long-term or sometimes
lifetime therapy. Anticonvulsant drugs are used in large quantities during long-term …
lifetime therapy. Anticonvulsant drugs are used in large quantities during long-term …
Epilepsy and antiepileptic drugs: risk factors for atherosclerosis
FM Talaat, T Kamel, AM Rabah… - International Journal …, 2015 - Taylor & Francis
Introduction: Epilepsy is a chronic disease that affects metabolism either alone or through
the antiepileptic drug (AED) treatment. A risk of atherosclerosis has been found in epileptic …
the antiepileptic drug (AED) treatment. A risk of atherosclerosis has been found in epileptic …
Effects of antiepileptic drugs on serum lipids profile among young adult Sudanese patient with epilepsy at Aljazeera State
TM Eltom, NE Mohamed, AM Bashir… - GSC Biological and …, 2021 - gsconlinepress.com
consequences that lead to an increase in risk of atherosclerosis in patients with epilepsy,
several studies have reported that the patients commonly used antiepileptic drugs like …
several studies have reported that the patients commonly used antiepileptic drugs like …
Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy
SA Hamed, EA Hamed, R Hamdy, T Nabeshima - Epilepsy research, 2007 - Elsevier
PURPOSE: This study aimed to evaluate the carotid artery intima-media thickness (CA-IMT)
in adult patients with epilepsy and its contribution to oxidative stress and vascular risk …
in adult patients with epilepsy and its contribution to oxidative stress and vascular risk …
Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids
E Płonka-Półtorak, P Zagrodzki, J Kryczyk-Kozioł… - Pharmacological …, 2016 - Elsevier
Background We aimed to demonstrate the relationship between the valproate (VPA)
treatment versus lipid and serum free fatty acids (FFAs) profiles to be the potential …
treatment versus lipid and serum free fatty acids (FFAs) profiles to be the potential …
The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy
T Nikolaos, G Stylianos, N Chryssoula… - Medical Science …, 2004 - medscimonit.com
Background: Antiepileptic drugs influence, among others, cholesterol and lipoprotein serum
levels. Material/Methods: Serum cholesterol (TC, HDL-c, and LDL-c) and triglyceride (TG) …
levels. Material/Methods: Serum cholesterol (TC, HDL-c, and LDL-c) and triglyceride (TG) …
Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy
DW Kim, SY Lee, YM Shon, JH Kim - Epilepsia, 2013 - Wiley Online Library
Although it is well documented that long‐term therapy with older antiepileptic drugs (AED s)
leads to an increase in risk for atherosclerosis, there has been only limited information …
leads to an increase in risk for atherosclerosis, there has been only limited information …
Effects of long‐term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis
Purpose: Long‐term therapy with antiepileptic drugs (AEDs) has been associated with
metabolic consequences that lead to an increase in risk of atherosclerosis in patients with …
metabolic consequences that lead to an increase in risk of atherosclerosis in patients with …
Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine
S Svalheim, G Luef, M Rauchenzauner… - Acta neurologica …, 2010 - Wiley Online Library
Svalheim S, Luef G, Rauchenzauner M, Mørkrid L, Gjerstad L, Taubøll E. Cardiovascular risk
factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. Acta Neurol …
factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. Acta Neurol …
Related searches
- patients with epilepsy valproic acid
- patients with epilepsy carbamazepine treatment
- valproic acid carbamazepine treatment
- valproic acid antiepileptic drugs
- valproic acid lipid profile
- valproic acid renal function
- lipid profile antiepileptic drugs
- long term antiepileptic drugs
- circulatory markers vascular risk
- effect of treatment antiepileptic drugs
- lipid profile effect of treatment
- risk factors antiepileptic drug
- aljazeera state antiepileptic drugs
- renal function antiepileptic drugs
- lipid profile renal function
- valproic acid effect of treatment